• 제목/요약/키워드: Regional recurrence

검색결과 183건 처리시간 0.027초

이하선에서 발견된 MALT 림프종 1례 (A Case report of MALT lymphoma in parotid gland)

  • 김명희;최종중;안홍근;박중수;김연수
    • 대한두경부종양학회지
    • /
    • 제35권1호
    • /
    • pp.33-36
    • /
    • 2019
  • Mucosa-associated lymphoid tissue (MALT) lymphoma has specific clinical and pathologic features. The most common site MALT lymphomas is the stomach; however, it can also occur in other organs, such as the salivary glands. MALT lymphoma is rare, but its prognosis is good. A 32-year-old man visited Konyang university hospital with parotid mass. Superficial partial parotidectomy was performed to exclude lymphoid neoplasms. IgH gene rearrangement analysis of the surgical specimen led to the diagnosis of MALT lymphoma. The patient underwent esophagogastroduodenoscopy, positron emission tomography-computed tomography, and whole-body bone scan. Regional or distant metastasis was not observed on staging workup. The patient underwent postoperative radiation therapy, there has been no recurrence of MALT lymphoma to date. Here, we report this rare case of parotid MALT lymphoma that was treated with surgery and postoperative radiation therapy.

Clear cell odontogenic carcinoma: a mini review

  • Kim, Young Hwan;Seo, Eun Jin;Park, Jae Kyung;Jang, Il Ho
    • International Journal of Oral Biology
    • /
    • 제44권3호
    • /
    • pp.77-80
    • /
    • 2019
  • Clear cell odontogenic carcinoma (CCOC), a very rare neoplasm located mostly in the mandible, has been regarded as a benign tumor. However, due to the accumulation of case reports, CCOC has been reclassified as a malignant entity by the World Health Organization. Patients with CCOC present with regional swelling and periodontal indications with variable pain, often remaining misdiagnosed for a long period. CCOC has slow growth but aggressive behavior, requiring radical resection. Histologic analysis revealed the monophasic, biphasic, and ameloblastic types of CCOC with clear cells and a mixed combination of polygonal and palisading cells. At the molecular level, CCOC shows the expression of cytokeratin and epithelial membrane antigen, along with markers that assign CCOC to the sarcoma family. At the genetic level, Ewing sarcoma breakpoint region 1-activating transcription factor 1 fusion is regarded as the key feature for identification. Nevertheless, the scarcity of cases and dependence on histological data delay the development of an efficient therapy. Regarding the high recurrence rate and the potential of distant metastasis, further characterization of CCOC is necessary for an early and accurate diagnosis.

Treatment of primary cutaneous anaplastic large cell lymphoma

  • Baik, Bong Soo;Lee, Wu Seop;Ji, So Young;Park, Ki Sung;Yang, Wan Suk;Kim, Sun Young
    • 대한두개안면성형외과학회지
    • /
    • 제20권3호
    • /
    • pp.207-211
    • /
    • 2019
  • Primary cutaneous anaplastic large cell lymphoma (C-ALCL) is a rare subtype of primary cutaneous lymphoma with a favorable prognosis. Primary cutaneous CD30+ lymphoproliferative disorders, which include C-ALCL and lymphomatoid papulosis, are the second most common group of cutaneous T-cell lymphomas. C-ALCL is comprised of large cells with anaplastic, pleomorphic, or immunoblastic cytomorphology, and indeed, more than 75% of the tumor cells express the CD30 antigen. C-ALCL clinically presents with solitary or localized reddish-brown nodules or tumors, and sometimes indurated papules, and they may be with ulceration covering with dark eschar. Multifocal lesions are seen in 20% of the patients. Extracutaneous dissemination, which mainly involves the regional lymph nodes, occurs in 10% of patients. A 69-year-old man noticed a mild elevated cutaneous lesion containing central ulceration covering with brownish black necrotic tissue on the right lower lip, and the lesion was surgically removed. After the first operation, another skin lesion was developed and the histological examination confirmed the diagnosis, C-ALCL. Eight specimens were excised during the 7-month follow-up period. The patient started the treatment with low-dose oral methotrexate (15 mg/wk) and there was no recurrence for 11 months.

국소 마취 하 굴곡 내시경 후두 레이저 수술로 치료한 성문 제자리 암종 1례 (Treatment of Carcinoma in Situ of Glottis by KTP Fiberoptic Laryngeal Laser Surgery Under Local Anesthesia)

  • 이윤지;이은상;박기남;이승원
    • 대한후두음성언어의학회지
    • /
    • 제30권1호
    • /
    • pp.53-56
    • /
    • 2019
  • The optimal treatments of carcinoma in situ of glottis include radiotherapy, laser surgery and vertical partial laryngectomy. Conventional surgical treatments need general anesthesia and radiotherapy has several complications. Recently, the effectiveness of 532 nm potassium titanyl phosphate (KTP) laser has been proven and widely used in vocal fold diseases even some cases of vocal fold dysplasia. A patient with difficult laryngeal exposure underwent fiberoptic laryngeal laser surgery using KTP laser under local anesthesia, showed improved voice outcome and the glottic lesion was removed successfully without local recurrence and regional metastasis 18 months after surgery.

아래 눈꺼풀에 발생한 원발성 피부 점액성 에크린 암종 1예 (Primary Cutaneous Mucinous Eccrine Carcinoma Arising in the Lower Eyelid: A Rare Case Report)

  • 용민준;신혜경;정규용;장태정;이준호
    • 대한두경부종양학회지
    • /
    • 제39권1호
    • /
    • pp.41-44
    • /
    • 2023
  • Mucinous Eccrine carcinoma (MEC) is a rare malignant tumor related to the eccrine sweat gland and is commonly located on the face, especially around the eyelids and scalp. Most of these tumors are diagnosed at age 40's to 60's and exhibit a wide variety of patterns in addition to the general appearance previously reported. MEC is difficult to diagnose clinically, but can be diagnosed by accompanying biopsy. We present the case of a 75-year-old man who complained of a gradually growing Left lower lid tumor of duration one year. Initially, the tumor was mistaken for an epidermal cyst and treated by surgical resection. However, biopsy findings resulted in a diagnosis of Mucinous Eccrine carcinoma. Therefore, we performed wide excision and flap reconstruction surgery. In a one year follow-up examination, the patient achieved successful functional and aesthetic results without regional or distant metastasis and recurrence.

Pancreatoduodenectomy following neoadjuvant chemotherapy in duodenal adenocarcinoma

  • Dongjin Seo;Bo Gyeom Park;Dawn Jung;Ho Kyoung Hwang;Sung Hyun Kim;Seung Soo Hong;Chang Moo Kang
    • 한국간담췌외과학회지
    • /
    • 제27권1호
    • /
    • pp.114-119
    • /
    • 2023
  • A 51-year-old male patient had four times of massive hematochezia episode three days before arrival. Carbohydrate antigen (CA) 19-9 level was extremely elevated. Computed tomography, magnetic resonance imaging, and positron emission tomography-computed tomography identified 5.7 cm sized periampullary duodenal cancer with regional metastatic lymph nodes and vascular invasion to aberrant right hepatic artery, main portal vein, and superior mesenteric vein. Diagnosed as duodenal adenocarcinoma through endoscopic biopsy, 16 times of FOLFIRI (5-fluorouracil, leucovorin, irinotecan) was conducted. The regimen changed to XELOX (capecitabine, oxaliplatine), four times of administration was done, and the CA19-9 level dramatically decreased. The tumor decreased to 2.1 cm. After R0 laparoscopic pylorus preserving pancreatoduodenectomy, no adjuvant therapy was given. No sign of recurrence or metastasis was reported, and the patient reached complete remission after five years. We reported a case where neoadjuvant chemotherapy for locally advanced duodenal adenocarcinoma was shown to be effective.

국소 재발된 유방암의 방사선치료 (Radiotherapy in Locoregional Recurrent Breast Carcinoma)

  • 하성환;양미경;정웅기;박찬일;방영주;김노경;최국진
    • Radiation Oncology Journal
    • /
    • 제6권2호
    • /
    • pp.203-209
    • /
    • 1988
  • 국소적으로 재발된 유방암의 경우, 근래에 와서 치료법의 발다로 관해율도 증가되고, 또한 환자의 수명도 연장시킬 수 있다는 보고가 증가되고 아울러 관심도 높아지고 있는 상태이다. 따라서 이런 국소 재발된 유방암을 가진 환자의 특성과 치료에 대한 실패양상, 그리고 예후에 영향을 미치는 인자들을 분석하여 이들 환자에 대한 치료에 도움이 되고자, 서울대학교 병원에서는 1979년에서 1986년까지 치료받은 총 33예에 대해서 분석을 하여 다음과 같은 결과를 얻었다. 15예(45%)에서 흉벽에 국한되어 재발하였고, 18예가 임파절에 재발을 하였다. 초기 치료후 36개월만에 87%가 재발을 보였다. 원전절제를 받아 방사선치료에 대한 판정을 할 수 없었던 8예를 제외한 25예에서 72%(18예)가 방사선치료 후 완전관해를 보였다. 국소재발 후 3년 동안의 생존율은 50%였다. 초기 치료후 2년이내 재발한 환자들의 3년 생존율은 24%였고, 2년 이후 재발한 경우는 100%였다. 흉벽에만 재발한 경우, 3년 생존율은 57%였고, 임파절에만 재발한 경우는 43%였다. 후자의 경우 대부분이 원격전이를 보였다. 완전관해를 보인 예와, 그렇지 않은 예에서는 각각 63%의 3년 생존율, 그리고 33%의 1년 생존율을 보였다. 3명의 환자가 대측 유방에 암을 보였다. 원발성 유방암에 대해서 수술과 전신치료를 함께 받은 경우 3년 생존율이 40%였고, 수술만 시행한 경우는 71%였다. 방사선 치료후 후속적 재발을 보인 경우의 2년 생존율은 25%였다.

  • PDF

제 1기 폐암의 수술성적 (The Surgical Results of Stage I Lung Cancer)

  • 김길동;정경영;홍기표;김대준
    • Journal of Chest Surgery
    • /
    • 제31권10호
    • /
    • pp.982-987
    • /
    • 1998
  • 연세대학교 의과대학 신촌세브란스병원 흉부외과에서는 1990년 1월부터 1996년 12월까지 원발성 폐암으로 폐절제술을 시행한 환자중 병리학적 병기가 제 1기인 146명을 대상으로 분석 하였다. 이중 남자는 115명, 여자가 31명이었고 나이는 27세에서 79세까지로 평균 58.9세 이었다. 세포병리학적 분류로 상피세포암이 7 2례(49.3%), 선암이 45례(30.8%)로 대부분 이었고, 수술은 전례에서 폐절제술과 종격동 임파절 박리술을 시행하였으며 폐엽 절제술이 96례(65.7%), 전폐 절제술이 48례(32.9%)이었다. 수술사망은 5례(3.4%), 합병증은 24례(16.5%)에서 발생하였다. 5년 생존율은 64.1% 이었으며 평균 생존기간은 66.5개월이었다. 예후인자별 분석에서 수술범위(p=0.1165), 세포형(p=0.8893)에 따른 생존율의 차이는 없었으며, 장측늑 막의 침윤 여부(p=0.0079), T1과 T2(p=0.0462), 선암에서 종양의 크기(>=5 cm)(p=0.0472)에 따른 생존율은 의미있는 차이를 보였다. 수술후 재발은 47례(33.3%)에서 발생 하였고, 이중 국소재발이 9례, 원격전이가 38례 이었다. 재발된 례중 대부분인 44례(93.7%)가 T2병변에서 재발되었고 3례(6.4%)만이 T1병변에서 재 발 되었다. 원격전이가 일어난 부위로는 반대편 폐가 13례로 가장 많았고 뇌 12례, 골 10례등 이었다. 결 론으로 장측늑막의 침윤, T2 병변, 선암에서 크기가 5 cm 이상인 경우에는 제 1기 폐암이라 할 지라도 수 술후 보조치료를 고려해 볼 수 있으리라 사료되었다.

  • PDF

Prognostic value of $^{18}F$-fluorodeoxyglucose positron emission tomography, computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with pathologically positive neck lymph node

  • Jwa, Eunjin;Lee, Sang-Wook;Kim, Jae-Seung;Park, Jin Hong;Kim, Su Ssan;Kim, Young Seok;Yoon, Sang Min;Song, Si Yeol;Kim, Jong Hoon;Choi, Eun Kyung;Ahn, Seung Do
    • Radiation Oncology Journal
    • /
    • 제30권4호
    • /
    • pp.173-181
    • /
    • 2012
  • Purpose: To evaluate the prognostic value of preoperative neck lymph node (LN) assessment with $^{18}F$-fluorodeoxyglucose positron emission tomography ($^{18}F$-FDG PET), computed tomography (CT), and magnetic resonance imaging (MRI) in oral cavity squamous cell carcinoma (OSCC) patients with pathologically positive LN. Materials and Methods: In total, 47 OSCC patients with pathologically positive LN were retrospectively reviewed with preoperative $^{18}F$-FDG PET and CT/MRI. All patients underwent surgical resection, neck dissection and postoperative adjuvant radiotherapy and/or chemotherapy between March 2002 and October 2010. Histologic correlation was performed for findings of $^{18}F$-FDG PET and CT/MRI. Results: Thirty-six (76.6%) of 47 cases were correctly diagnosed with neck LN metastasis by $^{18}F$-FDG PET and 32 (68.1%) of 47 cases were correctly diagnosed by CT/MRI. Follow-up ranged from 20 to 114 months (median, 56 months). Clinically negative nodal status evaluated by $^{18}F$-FDG PET or CT/MRI revealed a trend toward better clinical outcomes in terms of overall survival, disease-free survival, local recurrence-free survival, regional nodal recurrence-free survival, and distant metastasis-free survival rates even though the trends were not statistically significant. However, there was no impact of neck node standardized uptake value ($SUV_{max}$) on clinical outcomes. Notably, $SUV_{max}$ showed significant correlation with tumor size in LN (p < 0.01, $R^2$ = 0.62). PET and CT/MRI status of LN also had significant correlation with the size of intranodal tumor deposit (p < 0.05, $R^2$ = 0.37 and p < 0.01, $R^2$ = 0.48, respectively). Conclusion: $^{18}F$-FDG PET and CT/MRI at the neck LNs might improve risk stratification in OSCC patients with pathologically positive neck LN in this study, even without significant prognostic value of $SUV_{max}$.

위에 발생한 신경내분비 종양의 임상병리학적 고찰 (The Clinicopathologic Characteristics of Neuroendocrine Tumor of the Stomach)

  • 이철민;신연명
    • Journal of Gastric Cancer
    • /
    • 제8권4호
    • /
    • pp.204-209
    • /
    • 2008
  • 목적: 위에 발생하는 신경내분비 종양은 국내에서도 그 보고가 드문 매우 독특한 조직형인데, 이 종양의 임상병리학적 특징들에 대해 알아보고자 하였다. 대상 및 방법: 1999년 1월부터 2007년 8월까지 고신대학교 의과대학 외과학교실에서 위암으로 수술받은 4,159예 중 신경내분비 종양으로 진단받은 13예를 대상으로 의무기록 및 조직 표본을 후향적으로 분석하였다. 결과: 위 신경내분비 종양은 남자 11예, 여자 2예였고, 평균나이는 54.9세(42~72)였으며, 주증상은 상복부 통증과 속쓰림이 많았다. 점막 또는 점막하 종양 2예를 제외하고 나머지 9예는 모두 근육층 이상을 침범한 진행성이었고, 종양의 평균 크기는 7.0 cm (0.7~15)였다. WHO 분류법에 의한 내분비 종양의 유형은 제 3형이 8예, 제 4형이 4예, 제 1형이 1예였다. 림프절 전이는 11예에서 있었고, 추적 기간내 재발한 4명의 환자 모두 제 3형과 제 4형이었고, 재발한 장기는 간이 2예, 다장기(복막, 폐) 1예, 다장기(간, 췌장, 십이지장) 1예였고, 생존 기간은 평균 12.8개월이었다. 결론: 위에 발생하는 신경내분비 종양은 진단 당시 진행된 경우가 많았고 간 전이를 잘 하였으며 예후가 나쁜 독특한 조직형이다.

  • PDF